BREAST CANCER RESEARCH AND TREATMENT

SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma

Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience

Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study

Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer

Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study

Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer

Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project

Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing

GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event

Explaining variation in quality of breast cancer care and its impact: a nationwide population-based study from Slovenia

Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer

The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry

Propagation of functional estrogen receptor positive normal human breast cells in 3D cultures

Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations

Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes

Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications

Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties

Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II

Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study

A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy

Effects of tea consumption and the interactions with lipids on breast cancer survival

Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa

Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse

Effects of cyclic adjustment training delivered via a mobile device on psychological resilience, depression, and anxiety in Chinese post-surgical breast cancer patients

Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system

Racial differences in employment and cost-management behaviors in patients with metastatic breast cancer

Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers

A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy

Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis

Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)

Efficacy of intraoperative specimen radiography as margin assessment tool in breast conserving surgery

Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients

Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction

The impact of hospital volume on patient safety indicators following post-mastectomy breast reconstruction in the US

Breast density measured volumetrically in a clinical environment: cross-sectional study with photon counting technology

Molecular determinants of drug response in TNBC cell lines

Correction to: The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1

The use of contralateral prophylactic mastectomy among elderly patients in the United States

A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer

Improving surgical efficiency of immediate implant-based breast reconstruction following mastectomy

Letter regarding Sopik V et al. entitled “Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ”

Re: Association of depression and anxiety disorder with the risk of mortality in breast cancer

Proper treatment of breast angiosarcoma-mastectomy or breast conserving surgery?

Precision medicine: PI3K targeting in advanced breast cancer